Corvus Pharmaceuticals holds 2023 annual meeting; elects directors and ratifies auditor

Corvus Pharmaceuticals, Inc.

Stockholders elected Richard A. Miller, M.D. and Linda S. Grais, M.D., J.D. as Class I directors for three-year terms.
Ratified PricewaterhouseCoopers as independent auditor for FY2023 with 35.9M votes for, 0.1M against.
Non-binding advisory vote on executive compensation passed with 25.6M for, 0.4M against.
Total shares voted: 36.2M of 46.6M outstanding (77.6% turnout).

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Corvus Pharmaceuticals, Inc. shareholders approved Non-binding advisory vote to approve compensation of named executive officers at the 2023-06-15 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2023-06-15

Exact text from the filing

Votes For Votes Against Abstain Broker Non-Votes 25,550,695 348,929 177,941 10,073,471

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Corvus Pharmaceuticals, Inc. shareholders approved Ratification of selection of PricewaterhouseCoopers LLC as independent registered accounting firm at the 2023-06-15 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-06-15

Exact text from the filing

Votes For Votes Against Abstain 35,873,795 104,973 172,268

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Corvus Pharmaceuticals, Inc. shareholders approved Election of Class I directors at the 2023-06-15 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-06-15

Exact text from the filing

Class I Director Nominees Votes For Votes Withheld Broker Non-Votes Richard A. Miller, M.D. 26,009,538 68,027 10,073,471 Linda S. Grais, M.D. J.D. 25,210,111 867,454 10,073,471

View on SEC.gov

Browse all shareholder votes →

Corvus Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001171843-23-004019

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.